本页面由Tiger Trade Technology Pte. Ltd.提供服务

Coherus Biosciences

1.90
+0.02001.06%
盘后1.930.0291+1.53%18:42 EDT
成交量:164.50万
成交额:313.97万
市值:2.84亿
市盈率:1.32
高:1.96
开:1.87
低:1.85
收:1.88
52周最高:2.62
52周最低:0.7100
股本:1.49亿
流通股本:1.11亿
量比:1.79
换手率:1.48%
股息:- -
股息率:- -
每股收益(TTM):1.43
每股收益(LYR):1.43
净资产收益率:331.11%
总资产收益率:-31.20%
市净率:4.65
市盈率(LYR):1.32

数据加载中...

2020/05/07

重要事件披露

Current report, items 2.02 and 9.01
2020/04/17

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

8-K - Current report
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

重要事件披露

Current report, item 8.01
2020/01/24

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/01/24

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/01/15

重要事件披露

Current report, item 1.01
2020/01/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/02

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/20

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/18

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/08

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/06

SEC问询函

[Cover]Correspondence
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01